Generic Drugs Market | Market Highlights and Insights to Recovery from COVID-19
Market Forecast and Growth Projections 2021-2025
The Global generic drugs market is expected to grow by $ 138.90 bn, accelerating at a CAGR of 6.33% during the forecast period. Technavio’s research report traces the growth trajectory of the market and provides a detailed analysis of the prevalent market forces, trends, and drivers which are likely to impact the market in focus.
For a snapshot of our exhaustive research analysis and insights: Request for Our Free Sample Report
Generic Drugs Market: Segments and Leading Regions
This research report will provide insights into the current market share of each segment along with growth projections for the next five years.
- The Generic Drugs Market is segmented by Type (Small-molecule generics and Biosimilars) and Geography (North America, Europe, Asia, and ROW).
- In terms of geographic segmentation we found that 39% of the market growth will originate from North America during the forecast period. This report provides an accurate prediction of the contribution of all the geographic segments to the growth of the Generic Drugs Market size.
Generic Drugs Market: Trends, Drivers, Challenges
The research report looks at the impact of various trends, drivers, and challenges for market growth during the forecast period. These insights will enable clients to design a growth strategy for their business and area of operations.
- Low-cost alternatives will be a significant factor in driving the growth of the Generic Drugs Market.
- Increased outsourcing of drug discovery and development is another factor that will be instrumental in driving market growth during the forecast period.
- One of the key challenges that market players need to contend with in order to achieve further success is the Rising credibility issues.
Generic Drugs Market: Vendor Analysis
- The market is fragmented.
- The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions.
- Amgen Inc., Dr. Reddys Laboratories Ltd., Fresenius SE and Co. KGaA, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. are some of the major market participants.
For more insights into this market: Download a Free Sample Report. Our custom reports provide market insights at the global and regional level along with pipeline analysis of new product launches. It also provides a peek into the latest R&D along with an impact analysis of government regulations.
The report provides insights into the following FAQs:
- What is the market CAGR?
The market is accelerate at a CAGR of 6.33%.
- What is the incremental growth of the market?
The market is expected to grow by $ 138.90 bn through 2021-2025.
- What is a key factor driving this market?
Low-cost alternatives will drive market growth over the forecast period.
- What are the key regions covered in this market research report?
North America, Europe, Asia, and ROW are the key regions featured in this research report.
- Which is the leading geographic region for this market:
39% growth will originate from North America
- Who are the leading market vendors?
The leading vendors in this market are Amgen Inc., Dr. Reddys Laboratories Ltd., Fresenius SE and Co. KGaA, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.
- What are the market segments covered in this report?
The market is segmented by Type (Small-molecule generics and Biosimilars) and Geography (North America, Europe, Asia, and ROW)
Generic Drugs Market: Leading Regions and Market Trends
Geographical Analysis and Market Highlights 2021-2025
The generic drugs market is set to grow by $ 138.90 bn, accelerating at a CAGR of almost 6.33% during the forecast period. This research report analyses the growth trajectory of the market with a purview to prevalent market scenario, trends, and drivers. It also provides competitive bench-marking of the key market players and their product portfolios.
For more insights into our research and analysis: Request for our FREE Sample Report
Generic Drugs Market: North America to lead market growth during the forecast period
- 39% of the market growth will originate from North America during the forecast period. This report provides an accurate prediction of the contribution of all the geographic segments to the growth of the Generic Drugs Market size.
- Low-cost alternatives will be a significant factor in driving the growth of the generic drugs market. This report provides a detailed analysis of all the trends that are likely to influence the growth of individual segments within the market as well as the overall market in focus. This analysis will thus enable clients to assess their play in the market and plan for growth opportunities.
- The report segments the market by Type (Small-molecule generics and Biosimilars) and Geography (North America, Europe, Asia, and ROW). A detailed analysis of each segment and its contribution to the market share is provided along with factors that are likely to boost the market growth.
Generic Drugs Market: Key Competitors
Some of the leading vendors in this market are Amgen Inc., Dr. Reddys Laboratories Ltd., Fresenius SE and Co. KGaA, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. The market is fragmented and the growth of the players in this market is dependent on several factors such as prevalent market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions.
For more insights on this market: Download a Free Sample Report
The report provides insights into the following FAQs:
- What is the market CAGR?
The market is accelerate at a CAGR of 6.33%.
- What is the incremental growth of the market?
The market is expected to grow by $ 138.90 bn through 2021-2025.
- What is a key factor driving this market?
Low-cost alternatives will drive market growth over the forecast period.
- What are the key regions covered in this market research report?
North America, Europe, Asia, and ROW are the key regions featured in this research report.
- Which is the leading geographic region for this market:
39% growth will originate from North America
- Who are the leading market vendors?
The leading vendors in this market are Amgen Inc., Dr. Reddys Laboratories Ltd., Fresenius SE and Co. KGaA, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.
- What are the market segments covered in this report?
The market is segmented by Type (Small-molecule generics and Biosimilars) and Geography (North America, Europe, Asia, and ROW).
Market Segmentation by Type
- Generic Drugs Market Split by Type
- Small-molecule generics
- Biosimilars
- Generic Drugs Market Split by Geography
- North America
- Europe
- Asia
- ROW
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- APAC - Market size and forecast 2020-2025
- MEA - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- North America - Market size and forecast 2020-2025
- South America - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Competitive scenario
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Amgen Inc.
- Dr. Reddys Laboratories Ltd.
- Fresenius SE and Co. KGaA
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
